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Fig.　1　Gastrointestinal eosinophilic infl ammation. (A) Cluster of eosinophils in stool mucous. (×400, Hansel’s 
stain). (B) Pan-edema of esophageal wall in case 2. (C) Erythema on duodenal wall in case 2. (D) Erythema and 
erosion on colon wall in case 2. (E-F) Dense eosinophilic infi ltration of colon wall in case 2 (×100 & ×400).
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Dear Editor
Food Allergy after Cord Blood Stem Cell
Transplantation with Tacrolimus Therapy
in Two Patients Who Developed
Veno-Occlusive Disease
An increased prevalence of food allergy (FA) was
noted in tacrolimus-immunosuppressed young pediat-
ric liver transplant recipients.1 However, there have
so far been few cases of FA described after other
types of solid organ transplantation such as the kid-
ney2 or heart.3 In addition, to the best of our knowl-
edge, there has been no report of FA that developed
after cord blood stem cell transplantation (CBSCT)
and tacrolimus administration. We herein report 2 pa-
tients who developed FA-related gastrointestinal
symptoms after CBSCT using tacrolimus. Because
switching immunosuppressive drug therapy from
tacrolimus to Cyclosporin A (CsA) decreased the se-
rum levels of IgE in both cases, we believe that FA
was caused by the same mechanisms, as has been
previously reported in liver transplantation recipients
treated with tacrolimus.1,4 Interestingly, both of our
patients developed veno-occlusive disease (VOD) af-
ter CBSCT.
CASE REPORT 1
A 2-month-old Japanese male developed hemophago-
cytic lymphohistiocytosis and was diagnosed with fa-
milial hemophagocytic lymphohistiocytosis ( FHL )
type 2. At 6 months of age, CBSCT was performed.
(Donor HLA genotype was A*02: 07: 26: 01, B*15: 01:
46: 01, C*01: 02: 04: 01, DRB1*04: 03: 08: 03. Recipient
HLA genotype was A*02: 07: 26: 01, B*15: 01: 46: 01,
C*01: 02: 03: 03, DRB1*04: 05: 08: 03.) Graft-versus-
host disease ( GVHD ) prophylaxis consisted of
tacrolimus and short-term methotrexate. On day 9,
the patient developed VOD, which resolved following
the infusion of fresh frozen plasma and the admini-
stration of corticosteroids. GVHD in the acute phase
was seen only in the skin (grade I). Our patient ate a
regular diet with cow’s milk after the transplantation
and gradually avoided drinking milk. At 9 months of
age, he developed prolonged diarrhea accompanied
by poor weight gain. Infections were rule out based
on laboratory tests. He continued his regular diet, but
gradually developed dehydration and malnutrition
due to severe prolonged diarrhea and appetite loss.
This led to the institution of tube feeding. When he
was 24 months old, his height was 80.5 cm (-1.9 SD)
and his body weight was 9 kg (BMI z-score -1.8). A
blood test revealed eosinophilia and high levels of to-
tal serum IgE (1713 IUml). A serum analysis re-
vealed specific IgE antibody to egg white, milk, and
soybean, but not to aeroallergens. A stool smear
showed increased levels of eosinophils (Fig. 1A). The
diarrhea resolved after eliminating eggs, milk and
soybean from his diet. A food challenge test with
fresh cow’s milk caused diarrhea and increased the
number of eosinophils in his stool. Consequently, he
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was diagnosed to have having milk allergy. Because
he had been hospitalized for almost 1 year due to pro-
longed diarrhea, his guardians did not want us to per-
form any challenge tests for other foods, which would
extend the hospitalization. He did not show any
symptoms due to food hypersensitivity after starting
the elimination diet, but his total serum IgE concen-
tration gradually increased to 6515 IUml when he
was 30 months old. In addition, specific IgE to food al-
lergens, which was undetectable at 24 months of age,
became positive for rice and wheat. This led us to di-
agnose him as having tacrolimus-induced hypersensi-
tivity to multiple food allergens, a condition that has
previously been reported in liver transplantation. 1,4
We therefore switched the immunosuppressive drug
from tacrolimus to CsA. Following this, his total se-
rum IgE decreased to 1152 IUml and specific IgE to
rice or wheat also decreased within a month, thus
suggesting that tacrolimus contributed to producing
specific IgE to these food allergens.
CASE REPORT 2
Another 2-month-old Japanese male developed hemo-
phagocytic lymphohistiocytosis and was diagnosed
with FHL type 3. At 7 months of age, CBSCT was per-
formed with a similar regimen and the same GVHD
prophylaxis. (Donor HLA genotype was A*02: 01: 26:
01, B*35: 01N, C*03: 03N, DRB1*04: 10: 09: 01. The
recipient HLA genotype was A*02: 01: 26: 01, B*35:
01: 15: 11, C*03: 03N, DRB1*04: 10: 12: 01.) He also
developed VOD on day 6 after CBSCT. By age 15
months, he occasionally experienced vomiting and
frequent diarrhea. He also demonstrated appetite loss
leading to a poor weight gain. He especially avoided
eating all foods containing eggs. At 18 months of age,
his height was 74.8 cm (-2 SD) and his body weight
was 9 kg (BMI z-score 0). He was found to have high
total and allergen-specific serum IgE levels, as well as
a stool smear that showed increased levels of eosino-
phils. A food challenge test with dried whole egg
caused severe hives. Consequently, we diagnosed
him to have egg allergy. His guardians did not want
us to perform challenge tests for other foods because
the hives that developed after the egg challenge test
had been severe. His diarrhea improved within 1
month after eliminating eggs, milk and soybeans
from his diet. However, his loss of appetite did not
improve. The serum total IgE level increased to 4461
IUml when he was 23 months old. Gastrointestinal
endoscopy showed edema of the entire esophageal
wall and erythema with dense eosinophilic infiltration
in the walls of the stomach, duodenum and colon
(Fig. 1B-F). After switching his immunosuppressive
drug from tacrolimus to CsA and treating him with
prednisolone, he rapidly responded with an improved
appetite, and his total serum IgE level decreased to
408 IUml, thus suggesting that the eosinophilic in-
flammation leading to appetite loss may be related to
tacrolimus. However, the specific food allergens caus-
ing eosinophilic inflammation were unclear.
DISCUSSION
These are the first reported cases of FA after CBSCT
with tacrolimus treatment. Previous studies reported
that FA developed in approximately 20% of the pa-
tients in whom liver transplantation was performed
using tacrolimus, 1,5 while food allergy rarely oc-
curred after kidney transplantation using tacrolimus.2
In addition, a recent report showed that changing the
immunosuppressive drug from tacrolimus to CsA im-
proved the symptoms associated with FA.4 These ob-
servations strongly suggest that these types of
transplantation-associated FA are transplant organ-
and tacrolimus-related. Tacrolimus is thought to pro-
mote the development of FA because (i) it increases
the permeability of the small bowel, 6 which may
cause an increased absorption of food proteins, and
(ii) it suppresses Th1 cells more strongly than CsA,7
thus leading to Th2-skewing.8 Similar mechanisms
may have been involved in our cases.
FHL is a rare autosomal recessive disorder of im-
mune dysregulation associated with uncontrolled T
cell and macrophage activation and hypercytokine-
mia. FHL is fatal unless a hematopoietic stem cell
transplant is performed in infancy, when FA usually
develops. Both of our cases underwent CBSCT in in-
fancy, and this treatment modality was thought to
have increased their risk of developing FA.
VOD, another common feature in our patients, is a
syndrome characterized by rapid weight gain, ascites,
hepatomegaly, and jaundice. The pathogenesis of
VOD is thought to be due to damage to liver sinusoi-
dal endothelial cells (LSECs) and subsequent dam-
age to hepatocytes. 9 As tacrolimus-related food al-
lergy mainly occurs after liver transplantation but
rarely after other types of solid organ transplantation,
we suppose that liver damages due to VOD might
contribute to the development of FA in our cases. In
the liver, hepatic sinusoids are lined by LSECs and
naïve T cells recirculating within the sinusoids can be
in direct contact with Kupffer cells or LSECs located
within the lumen of the sinusoids. 10 It has been
shown that Kupffer cells, LESCs and liver dendritic
cells uptake and present gut-derived antigens, includ-
ing food allergens, to naïve T cells, thus resulting in
immune tolerance both in CD8+ T cells and CD4+ T
cells.10 Therefore, it is possible that VOD-associated
damages to the liver, especially to these cells that can
induce immune tolerance, might have suppressed
oral tolerance to food allergens and promoted the de-
velopment of FA in our patients.
Because we could not check for sensitization in the
CBSC donors due to the establishment of privacy re-
strictions imposed by the Japanese cord blood bank
network, we cannot rule out the possibility that the
transferred immune cells themselves may have led to
FA after Cord Blood Transplantation
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the development of the FA observed in our cases.
However, the time from transplantation to the devel-
opment of FA would most likely have been shorter if
the transferred food allergen-specific immune cells
caused the disease.
Our cases strongly suggested that FA needs to be
considered after SCT, as well as in liver transplanta-
tion, in which tacrolimus is used to suppress GVHD.
Moreover, further investigation of the mechanisms
that lead to the development of FA after liver trans-
plantation or severe liver damage might provide help-
ful clues to elucidate precisely how oral tolerance be-
comes established and how it can be abrogated.
We thank to Dr. Fred D. Finkelman and Dr. Brian
Quinn for reviewing manuscript.
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